Get the app!
Back to Trades
Other4

Pasithea Therapeutics Corp.

KTTA

Total Value
$30.7K

Company Information

Ticker Symbol
KTTA
CIK
0001841330

Insider Information

Role
Director
Director
Location
MIAMI BEACH, FL

Filing Details

Filing Date
Oct 27, 2025
Transaction Date
Oct 24, 2025
Accession Number
0001213900-25-102680
Form Type
4

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Oct 24, 2025Derivative42,913$0.71Grant/Award$30.7K

Footnotes

  1. (F1)The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.